Literature DB >> 24775578

Vasectomy as a reversible form of contraception for select patients.

Mary K Samplaski1, Ariande Daniel, Keith Jarvi.   

Abstract

INTRODUCTION: To provide an effective form of birth control, men may choose a reversible or permanent form of contraception. Vasectomy is presently offered as a permanent option for male contraception. We have had patients who were interested in vasectomy and reversal as a temporary birth control option. The purpose of this paper is to determine if vasectomy should be offered for selected couples as a temporary form of contraception and under which circumstances.
MATERIALS AND METHODS: A literature review was conducted to determine the available reversible contraceptive options, risks, failure rates and contraindications to each, and the risks and success rates of vasectomy and vasectomy reversal.
RESULTS: Reversible contraceptives include hormonally based methods for women, non-hormonal anatomic barrier devices and spermatocidal agents. Hormone based therapies may be contraindicated in women with cardiovascular disease, hypertension, and some cancers. Non-hormonal contraceptives are generally less effective and may be unacceptable for some couples due to higher failure rates, difficulty of use and lack of acceptance. Both vasectomy and vasectomy reversal are low risk procedures. Reversal may be performed with a high degree of success, particularly with a short obstructive interval (97% patency if performed < 3 years following vasectomy).
CONCLUSION: While vasectomy should be considered a permanent form of sterilization for most couples, there are select couples, unable or unwilling to use other forms of birth control, who would benefit from an informed discussion about using a vasectomy as a reversible form of contraception.

Entities:  

Mesh:

Year:  2014        PMID: 24775578

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  3 in total

1.  CUA guideline: Vasectomy.

Authors:  Armand Zini; John Grantmyre; Peter Chan
Journal:  Can Urol Assoc J       Date:  2016-08-16       Impact factor: 1.862

2.  UPDATE - 2022 Canadian Urological Association best practice report: Vasectomy.

Authors:  Armand Zini; John Grantmyre; Victor Chow; Peter Chan
Journal:  Can Urol Assoc J       Date:  2022-05       Impact factor: 2.052

Review 3.  Vasectomy and cardiovascular disease risk: A systematic review and meta-analysis.

Authors:  Zhen-Lang Guo; Jing-Li Xu; Ren-Kui Lai; Shu-Sheng Wang
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.